Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Price:
965.5
GBX
Market Cap:
£62.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
UK |
|
Green Envirotech Holdings Corp
OTC:GETH
|
US |
|
C
|
Corner Growth Acquisition Corp 2
NASDAQ:TRON
|
US |
|
Democrasoft Inc
OTC:DEMO
|
US |
Cash Flow Statement
Cash Flow Statement
Hemogenyx Pharmaceuticals PLC
Hemogenyx Pharmaceuticals PLC
Currency: GBP
| Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(0)
|
(0)
|
(2)
|
(3)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(5)
|
(5)
|
(3)
|
(4)
|
(7)
|
(7)
|
(5)
|
(6)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
(0)
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
1
|
1
|
|
| Cash from Operating Activities |
(1)
N/A
|
(0)
+25%
|
(0)
-11%
|
(1)
-144%
|
(1)
-23%
|
(1)
-3%
|
(1)
+14%
|
(1)
-9%
|
(2)
-38%
|
(2)
-18%
|
(3)
-24%
|
(2)
+6%
|
(3)
-18%
|
(5)
-84%
|
(6)
-14%
|
(5)
+17%
|
(4)
+18%
|
(6)
-35%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-7%
|
1
N/A
|
1
-1%
|
(0)
N/A
|
0
N/A
|
0
-52%
|
0
-13%
|
(0)
N/A
|
(0)
-4%
|
(1)
-434%
|
(1)
+1%
|
(0)
+55%
|
(0)
+10%
|
(0)
+92%
|
(0)
-76%
|
(0)
+97%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
1
|
1
|
2
|
2
|
0
|
0
|
0
|
3
|
3
|
12
|
12
|
0
|
0
|
4
|
5
|
4
|
4
|
3
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
0
|
1
|
0
|
(0)
|
0
|
0
|
(2)
|
(3)
|
(2)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
1
-1%
|
1
+62%
|
1
+0%
|
1
-3%
|
1
0%
|
(0)
N/A
|
4
N/A
|
3
-10%
|
9
+195%
|
9
-7%
|
(1)
N/A
|
(0)
+90%
|
3
N/A
|
4
+27%
|
4
-17%
|
3
-17%
|
2
-38%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
2
|
|
| Net Change in Cash |
0
N/A
|
0
+271%
|
2
+1 113%
|
1
-36%
|
(0)
N/A
|
(0)
-32%
|
(1)
-741%
|
2
N/A
|
1
-42%
|
7
+448%
|
5
-30%
|
(5)
N/A
|
(4)
+10%
|
(3)
+37%
|
(1)
+53%
|
(1)
-12%
|
(1)
+25%
|
(1)
-30%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
+17%
|
(1)
+15%
|
(1)
-128%
|
(1)
-17%
|
(1)
-2%
|
(1)
+14%
|
(1)
-8%
|
(2)
-50%
|
(2)
-17%
|
(3)
-49%
|
(3)
+5%
|
(3)
-2%
|
(6)
-74%
|
(6)
-7%
|
(5)
+17%
|
(4)
+20%
|
(6)
-35%
|
|
Switch to:
Switch to:
See Also
Discover More
